- Home
- NUE vs IQV Comparison
NUE vs IQV Comparison
Compare NUE & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUE
- IQV
- Stock Information
- Founded
- NUE 1905
- IQV 1982
- Country
- NUE United States
- IQV United States
- Employees
- NUE N/A
- IQV N/A
- Industry
- NUE Steel/Iron Ore
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- NUE Industrials
- IQV Health Care
- Exchange
- NUE Nasdaq
- IQV Nasdaq
- Market Cap
- NUE 34.5B
- IQV 38.1B
- IPO Year
- NUE N/A
- IQV 2013
- Fundamental
- Price
- NUE $149.56
- IQV $195.83
- Analyst Decision
- NUE Buy
- IQV Buy
- Analyst Count
- NUE 7
- IQV 16
- Target Price
- NUE $190.57
- IQV $256.60
- AVG Volume (30 Days)
- NUE 2.1M
- IQV 2.2M
- Earning Date
- NUE 10-21-2024
- IQV 10-31-2024
- Dividend Yield
- NUE 1.45%
- IQV N/A
- EPS Growth
- NUE N/A
- IQV 27.98
- EPS
- NUE 10.40
- IQV 7.62
- Revenue
- NUE $31,362,946,000.00
- IQV $15,315,000,000.00
- Revenue This Year
- NUE N/A
- IQV $3.68
- Revenue Next Year
- NUE $1.14
- IQV $4.89
- P/E Ratio
- NUE $14.26
- IQV $25.35
- Revenue Growth
- NUE N/A
- IQV 3.10
- 52 Week Low
- NUE $133.42
- IQV $187.62
- 52 Week High
- NUE $203.00
- IQV $261.73
- Technical
- Relative Strength Index (RSI)
- NUE 47.17
- IQV 30.04
- Support Level
- NUE $143.71
- IQV $187.62
- Resistance Level
- NUE $149.94
- IQV $194.48
- Average True Range (ATR)
- NUE 4.33
- IQV 7.50
- MACD
- NUE -0.71
- IQV -1.67
- Stochastic Oscillator
- NUE 20.49
- IQV 14.34
About NUE Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products, and raw materials, the steel mills segment derives maximum revenue. The steel mills segment includes carbon and alloy steel in sheet, bars, structural and plate; steel trading businesses; rebar distribution businesses; and Nucor's equity method investments in NuMit and NJSM.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.